Life Sciences

The company utilizes machine learning and patient data to deliver personalized medication management pertaining to polypharmacy.

The purchase comes on the heels of the surgical navigation platform's $82.5 million Series D raise in June.

The company will use the investment to fuel the expansion of Paradigm,its FDA-cleared, AI-enabled surgical navigation platform.

The multiple sclerosis-focused company will use the funds to speed up the company's commercialization efforts.

GenHealth AI, maker of what it calls a large medical model, and senior-focused startup K4Connnect also secured investment.

Edward Shi and Paras Unadkat, product managers at Google, tell MobiHealthNews how their teams worked together to build the Pixel Watch's fall-detection features.

Mental health company UpLift and electrophysiology-focused medical technology company CathVision also garnered investment.

The Ohio-based company's XR90 offering allows physicians to view a patient's anatomical structures in 3D for preoperative and intraoperative use. 

The round brings the company's total raise to $93 million.

Naomi Fried, founder and CEO of PharmStars, discusses the 13 startups from its spring cohort and its call for applications for its fall 2023 cohort, Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.